Back

SGLT2i in heart failure with reduced ejection fraction: benefits in real life?

20 May 2023 (08:00 - 20:00)
Organised by: Logo
Congress Presentation Part of: ePosters in chronic heart failure - heart failure with reduced ejection fraction (HFrEF) 3 Heart Failure with Reduced Ejection Fraction (HFrEF) HFA Premium Access Heart Failure 2023 Heart Failure Association (HFA)

About the speaker

Photo
Doctor Virtudes Sanchez Gonzalez

Complex Public Hospital Virgen del Rocio Regional, Sevilla, Spain (Spain)

5 More presentations in this session

Presentation thumbnail
Evaluation of the mortality rate in patients with hfref with LVEF less than 25% in a specialized outpatient clinic
Mr F. Grillo (Curitiba, BR)
Abstract Slides
Presentation thumbnail
Effects of dapagliflozin on left ventricular global longitudinal strain correlated with basal functional capacity
Doctor G. De Masi De Luca (Tricase, IT)
Abstract Slides
Presentation thumbnail
Investigations to determine the underlying aetiology of heart failure: do we really follow the guidelines in real life?
Mr A. Adeba Garcia (Oviedo, ES)
Abstract Slides
Presentation thumbnail
BNP, age, serum sodium, hemoglobin and creatinine clearence: a new simple chronic HF prognostic index
Doctor A. Fonseca (Porto, PT)
Abstract Slides
Presentation thumbnail
Different cardioprotection protocols for elective heart surgery surgery in patients with advanced left ventricular failure- a comparison of del Nido and cold blood cardioplegia.
Mrs M. Synak (Krakow, PL)
Abstract Slides

Access the full session

Session thumbnail
ePosters in chronic heart failure - heart failure with reduced ejection fraction (HFrEF) 3

The Event

Event poster

Heart Failure 2023

20 May - 23 May 2023
You may be interested in
thumbnail
Congress Presentation
Distinguishing heart failure with reduced ejection fraction from heart failure with preserved ejection fraction: a phenomics approach.
thumbnail
Congress Presentation
Clinical characteristics and long-term prognosis of patients with heart failure with reduced, mildly reduced, and preserved left ventricular ejection fraction secondary to Chagas cardiomyopathy
thumbnail
Congress Session
Meet the Experts: summation of the science - treatment of chronic heart failure in 2023

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources